| P2093 | author name string | Ahmet Sezer | |
| | Ahmet Taner Sümbül | |
| | Fatih Köse | |
| | Hüseyin Abalı | |
| | Özgür Özyılkan | |
| | Hüseyin Mertsoylu | |
| | Sadık Muallaoğlu | |
| | Ilhami Gültepe | |
| P2860 | cites work | Global cancer statistics | Q22241238 |
| | Hallmarks of Cancer: The Next Generation | Q22252312 |
| | Cancer-related inflammation | Q27860907 |
| | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 |
| | Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer | Q29616218 |
| | Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling? | Q33921803 |
| | Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer. | Q34079559 |
| | Circulating tumor cells as biomarkers in prostate cancer | Q34193303 |
| | Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer | Q34919435 |
| | The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma | Q36353298 |
| | Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram | Q36483161 |
| | Clinical significance of preoperative inflammatory parameters in gastric cancer patients | Q36993466 |
| | Monitoring the clinical outcomes in advanced prostate cancer: what imaging modalities and other markers are reliable? | Q38117463 |
| | Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer | Q42985641 |
| | Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. | Q43686080 |
| | Systemic inflammatory response in gastric cancer | Q44284760 |
| | The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. | Q46634652 |
| | The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. | Q46833943 |
| | High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. | Q51536892 |
| | Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment | Q81091447 |
| | Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer | Q81105891 |
| | Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy | Q83739138 |
| | Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer | Q84958080 |
| P433 | issue | 8 | |
| P921 | main subject | prostate cancer | Q181257 |
| | lymphocyte | Q715347 |
| P304 | page(s) | 1531-1535 | |
| P577 | publication date | 2014-02-13 | |
| P1433 | published in | International Urology and Nephrology | Q15763616 |
| P1476 | title | Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel | |
| P478 | volume | 46 | |